ZA201500606B - Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine - Google Patents
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccineInfo
- Publication number
- ZA201500606B ZA201500606B ZA2015/00606A ZA201500606A ZA201500606B ZA 201500606 B ZA201500606 B ZA 201500606B ZA 2015/00606 A ZA2015/00606 A ZA 2015/00606A ZA 201500606 A ZA201500606 A ZA 201500606A ZA 201500606 B ZA201500606 B ZA 201500606B
- Authority
- ZA
- South Africa
- Prior art keywords
- mva
- rsv
- vaccine
- respiratory syncytial
- modified vaccinia
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261678367P | 2012-08-01 | 2012-08-01 | |
EP12005594 | 2012-08-01 | ||
PCT/EP2013/055483 WO2014019718A1 (en) | 2012-08-01 | 2013-03-15 | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201500606B true ZA201500606B (en) | 2020-05-27 |
Family
ID=66440168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2015/00606A ZA201500606B (en) | 2012-08-01 | 2015-01-27 | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
Country Status (8)
Country | Link |
---|---|
JP (2) | JP6895944B2 (en) |
DK (1) | DK2879702T3 (en) |
ES (1) | ES2767324T3 (en) |
HU (1) | HUE047102T2 (en) |
LT (1) | LT2879702T (en) |
PT (1) | PT2879702T (en) |
UA (1) | UA123385C2 (en) |
ZA (1) | ZA201500606B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2879702T3 (en) * | 2012-08-01 | 2020-02-24 | Bavarian Nordic As | RECOMBINANT MODIFIED VACCINIAVIRUS ANKARA (VAT) -VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008114149A2 (en) * | 2007-03-21 | 2008-09-25 | Id Biomedical Corporation Of Quebec | Chimeric antigens |
CA2770304C (en) * | 2009-08-04 | 2019-11-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Anti-rsv immunogens and methods of immunization |
US9173933B2 (en) * | 2010-10-15 | 2015-11-03 | Bavarian Nordic A/S | Recombinant modified vaccinia virus Ankara influenza vaccine |
WO2012085936A2 (en) * | 2010-12-20 | 2012-06-28 | Panacea Biotech Ltd | Recombinant respiratory syncytial virus plasmids and vaccines |
WO2012089231A1 (en) * | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
KR20220119527A (en) * | 2012-08-01 | 2022-08-29 | 버베리안 노딕 에이/에스 | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
DK2879702T3 (en) * | 2012-08-01 | 2020-02-24 | Bavarian Nordic As | RECOMBINANT MODIFIED VACCINIAVIRUS ANKARA (VAT) -VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) |
-
2013
- 2013-03-15 DK DK13717721.8T patent/DK2879702T3/en active
- 2013-03-15 ES ES13717721T patent/ES2767324T3/en active Active
- 2013-03-15 UA UAA201501765A patent/UA123385C2/en unknown
- 2013-03-15 LT LTEP13717721.8T patent/LT2879702T/en unknown
- 2013-03-15 PT PT137177218T patent/PT2879702T/en unknown
- 2013-03-15 HU HUE13717721A patent/HUE047102T2/en unknown
-
2015
- 2015-01-27 ZA ZA2015/00606A patent/ZA201500606B/en unknown
-
2018
- 2018-12-26 JP JP2018242562A patent/JP6895944B2/en active Active
-
2021
- 2021-06-04 JP JP2021094027A patent/JP7317896B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
DK2879702T3 (en) | 2020-02-24 |
LT2879702T (en) | 2020-02-10 |
HUE047102T2 (en) | 2020-04-28 |
ES2767324T3 (en) | 2020-06-17 |
PT2879702T (en) | 2020-02-04 |
JP2019068833A (en) | 2019-05-09 |
UA123385C2 (en) | 2021-03-31 |
JP2021137023A (en) | 2021-09-16 |
JP7317896B2 (en) | 2023-07-31 |
JP6895944B2 (en) | 2021-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205459A1 (en) | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine (mva)(rsv) | |
SG11201510746WA (en) | Respiratory syncytial virus (rsv) vaccine | |
HK1222125A1 (en) | Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus rsv f | |
IL258831A (en) | Respiratory syncytial virus vaccine | |
AP2014007993A0 (en) | Vaccine against RSV | |
PT2939692T (en) | Nasal influenza vaccine composition | |
PT2806891T (en) | Parainfluenza virus 5 based vaccines | |
GB2506621B (en) | Respiratory mask | |
EP2432503A4 (en) | Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva) | |
IL240504A0 (en) | Combination vaccine for respiratory syncytial virus and influenza | |
EP2631290A4 (en) | Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector | |
EP2940134A4 (en) | Vaccine prepared utilizing human parainfluenza virus type 2 vector | |
EP2753354A4 (en) | Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine | |
HK1223644A1 (en) | Semi-live respiratory syncytial virus vaccine | |
EP3057611A4 (en) | Thermostable respiratory synctial virus (rsv) vaccine compositions | |
EP3053593A4 (en) | Nasal mucosal vaccine composition | |
HK1223643A1 (en) | Semi-live respiratory syncytial virus vaccine | |
EP2929893A4 (en) | Adjuvant for mucous membrane vaccine | |
EP3046578A4 (en) | Recombinant respiratory syncytial virus (rsv) and vaccines | |
EP2839840A4 (en) | Recombinant trivalent vaccine against human influenza | |
ZA201500606B (en) | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine | |
GB201215184D0 (en) | Therapeutic virus | |
HK1206272A1 (en) | Vaccine against rsv rsv |